Connection

Carol Sherman to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Carol Sherman has written about Protein Kinase Inhibitors.
Carol Sherman
Connection Strength
0.101
Protein Kinase Inhibitors
  1. Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib. J Thorac Oncol. 2015 Feb; 10(2):232-6.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.